Maverick Citizen New drug-resistant TB medicines will save lives but high costs remain a concern for health equity By Daniel Steyn and Nathan Geffen
South Africa Shorter, simpler drug-resistant TB treatment expected in SA later in 2022 By Catherine Tomlinson